- Robert Jack
- January 8, 2026
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare
Cybersecurity and PHI Exposure: The New Board-Level M&A Risk in Healthcare Key Takeaways Introduction Healthcare mergers and acquisitions are no longer judged solely on revenue, patient volume, or EBITDA multiples. In today’s environment, cybersecurity posture and PHI exposure have become decisive factors in whether a deal closes, how it is priced, and who ultimately bears […]
Read MoreRecent Posts
- Why Bigger Healthcare Companies Face Greater Regulatory Scrutiny in M&A Transactions
- A Better Sale Story: How Healthcare Owners Frame Value Without Overselling
- The Process Premium: Why Organized Healthcare Sales Often Win Better Terms
- The Leverage Window: When Healthcare Sellers Have Power — and When They Lose It
- Behind the Offer: What Buyers Are Really Thinking in Healthcare M&A
Recent Comments
Latest Post
Tags
dental practice M&A dental practice sale due diligence exit planning healthcare acquisitions healthcare business broker healthcare business brokers healthcare business sale healthcare business valuation healthcare compliance healthcare consolidation healthcare deal preparation healthcare deal structuring healthcare due diligence healthcare exit planning healthcare exit strategy healthcare investment healthcare M&A healthcare m&a advisors healthcare M&A advisory healthcare M&A agency healthcare m&a broker healthcare M&A firm healthcare M&A firms healthcare mergers healthcare mergers and acquisitions healthcare practice sale healthcare private equity healthcare transaction advisory healthcare transactions healthcare valuation m&a healthcare advisors MedBridge Capital medical practice sale medical practice valuation MedSpa business brokers medspa M&A medspa valuation operational efficiency practice valuation private equity healthcare private equity healthcare deals private equity MedSpa selling a medical practice sell medical practice